Coloplast A/S Valuation
| CLPBF Stock | USD 110.98 2.28 2.10% |
At this time, the firm appears to be overvalued. Coloplast A/S shows a prevailing Real Value of $103.21 per share. The current price of the firm is $110.98. Our model approximates the value of Coloplast A/S from analyzing the firm fundamentals such as Profit Margin of 0.20 %, current valuation of 28.84 B, and Return On Equity of 0.75 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Coloplast A/S's price fluctuation is very steady at this time. Calculation of the real value of Coloplast A/S is based on 3 months time horizon. Increasing Coloplast A/S's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Coloplast pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Coloplast AS. Since Coloplast A/S is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Coloplast Pink Sheet. However, Coloplast A/S's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 110.98 | Real 103.21 | Hype 110.98 | Naive 107.68 |
The real value of Coloplast Pink Sheet, also known as its intrinsic value, is the underlying worth of Coloplast A/S Company, which is reflected in its stock price. It is based on Coloplast A/S's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Coloplast A/S's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Coloplast AS helps investors to forecast how Coloplast pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Coloplast A/S more accurately as focusing exclusively on Coloplast A/S's fundamentals will not take into account other important factors: Coloplast A/S Total Value Analysis
Coloplast AS is currently forecasted to have takeover price of 28.84 B with market capitalization of 24.87 B, debt of 16.36 B, and cash on hands of 854 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Coloplast A/S fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
28.84 B | 24.87 B | 16.36 B | 854 M |
Coloplast A/S Investor Information
About 35.0% of the company shares are held by company insiders. The company last dividend was issued on the 2nd of December 2022. Coloplast A/S had 5:1 split on the 19th of December 2012. Based on the key indicators related to Coloplast A/S's liquidity, profitability, solvency, and operating efficiency, Coloplast AS is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Coloplast A/S Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Coloplast A/S has an asset utilization ratio of 64.59 percent. This implies that the Company is making $0.65 for each dollar of assets. An increasing asset utilization means that Coloplast AS is more efficient with each dollar of assets it utilizes for everyday operations.Coloplast A/S Ownership Allocation
Coloplast A/S holds a total of 194.31 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Coloplast A/S Profitability Analysis
The company reported the revenue of 22.58 B. Net Income was 4.71 B with profit before overhead, payroll, taxes, and interest of 15.53 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Coloplast A/S's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Coloplast A/S and how it compares across the competition.
About Coloplast A/S Valuation
The pink sheet valuation mechanism determines Coloplast A/S's current worth on a weekly basis. Our valuation model uses a comparative analysis of Coloplast A/S. We calculate exposure to Coloplast A/S's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Coloplast A/S's related companies.Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.
8 Steps to conduct Coloplast A/S's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Coloplast A/S's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Coloplast A/S's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Coloplast A/S's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Coloplast A/S's revenue streams: Identify Coloplast A/S's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Coloplast A/S's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Coloplast A/S's growth potential: Evaluate Coloplast A/S's management, business model, and growth potential.
- Determine Coloplast A/S's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Coloplast A/S's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Coloplast A/S Growth Indicators
Investing in growth stocks can be very risky. If the company such as Coloplast A/S does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 209.1 M | |
| Quarterly Earnings Growth Y O Y | -0.063 | |
| Forward Price Earnings | 33.4448 | |
| Retained Earnings | 8.6 B |
Complementary Tools for Coloplast Pink Sheet analysis
When running Coloplast A/S's price analysis, check to measure Coloplast A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast A/S is operating at the current time. Most of Coloplast A/S's value examination focuses on studying past and present price action to predict the probability of Coloplast A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast A/S's price. Additionally, you may evaluate how the addition of Coloplast A/S to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |